Currently, Ian Ayton is directly involved with the development
of a revolutionary implantable vascular device for a startup
company in Santa Rosa California. His initial involvement, along
with the primary inventor, was to create a prototype of the
device sufficient to demonstrate the feasibility of the concept
to a level that would encourage the acquisition of venture
capital. Eighteen months later the company has grown from the
original three to almost 40 employees. Project progress has been
so encouraging that investment capital is now easy to obtain, in
fact offers for capital are currently being turned down. Ian is
still involved with some of the more challenging problems on
this project that still require resolution.
|
|